BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22492694)

  • 1. Inhibition of Syk activity by R788 in platelets prevents remote lung tissue damage after mesenteric ischemia-reperfusion injury.
    Lapchak PH; Kannan L; Rani P; Pamuk ON; Ioannou A; Dalle Lucca JJ; Pine P; Tsokos GC
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1416-22. PubMed ID: 22492694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.
    Pamuk ON; Lapchak PH; Rani P; Pine P; Dalle Lucca JJ; Tsokos GC
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G391-9. PubMed ID: 20522642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion.
    Lapchak PH; Kannan L; Ioannou A; Rani P; Karian P; Dalle Lucca JJ; Tsokos GC
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G888-97. PubMed ID: 22301111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury.
    Lapchak PH; Ioannou A; Kannan L; Rani P; Dalle Lucca JJ; Tsokos GC
    PLoS One; 2012; 7(2):e32260. PubMed ID: 22384195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-κB and spleen tyrosine kinase activation.
    Ishizuka F; Shimazawa M; Inoue Y; Nakano Y; Ogishima H; Nakamura S; Tsuruma K; Tanaka H; Inagaki N; Hara H
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5807-16. PubMed ID: 23908181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets activated by collagen through the immunoreceptor tyrosine-based activation motif in the Fc receptor gamma-chain play a pivotal role in the development of myocardial ischemia-reperfusion injury.
    Takaya N; Katoh Y; Iwabuchi K; Hayashi I; Konishi H; Itoh S; Okumura K; Ra C; Nagaoka I; Daida H
    J Mol Cell Cardiol; 2005 Dec; 39(6):856-64. PubMed ID: 16246361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury.
    Lapchak PH; Ioannou A; Rani P; Lieberman LA; Yoshiya K; Kannan L; Dalle Lucca JJ; Kowalska MA; Tsokos GC
    PLoS One; 2012; 7(7):e39934. PubMed ID: 22792197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets.
    Liu X; Yan Y; Bao L; Chen B; Zhao Y; Qi R
    Thromb Res; 2014 Nov; 134(5):1066-73. PubMed ID: 25223809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
    J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.
    Lhermusier T; van Rottem J; Garcia C; Xuereb JM; Ragab A; Martin V; Gratacap MP; Sié P; Payrastre B
    J Thromb Haemost; 2011 Oct; 9(10):2067-76. PubMed ID: 21848694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
    Suljagic M; Longo PG; Bennardo S; Perlas E; Leone G; Laurenti L; Efremov DG
    Blood; 2010 Dec; 116(23):4894-905. PubMed ID: 20716772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis.
    Smith J; McDaid JP; Bhangal G; Chawanasuntorapoj R; Masuda ES; Cook HT; Pusey CD; Tam FW
    J Am Soc Nephrol; 2010 Feb; 21(2):231-6. PubMed ID: 19959716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets.
    Getz TM; Manne BK; Buitrago L; Mao Y; Kunapuli SP
    Thromb Haemost; 2013 Jun; 109(6):1131-40. PubMed ID: 23571309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "Therapeutic targeting of Syk in autoimmune diabetes".
    Kapoor S
    J Immunol; 2011 Feb; 186(4):1885; author reply 1886-5. PubMed ID: 21289311
    [No Abstract]   [Full Text] [Related]  

  • 16. Spleen Tyrosine Kinase Signaling Promotes Myeloid Cell Recruitment and Kidney Damage after Renal Ischemia/Reperfusion Injury.
    Ryan J; Kanellis J; Blease K; Ma FY; Nikolic-Paterson DJ
    Am J Pathol; 2016 Aug; 186(8):2032-2042. PubMed ID: 27322771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life.
    Hess PR; Rawnsley DR; Jakus Z; Yang Y; Sweet DT; Fu J; Herzog B; Lu M; Nieswandt B; Oliver G; Makinen T; Xia L; Kahn ML
    J Clin Invest; 2014 Jan; 124(1):273-84. PubMed ID: 24292710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice.
    Nocito A; Georgiev P; Dahm F; Jochum W; Bader M; Graf R; Clavien PA
    Hepatology; 2007 Feb; 45(2):369-76. PubMed ID: 17256748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2.
    Mayanglambam A; Dangelmaier CA; Thomas D; Damodar Reddy C; Daniel JL; Kunapuli SP
    Platelets; 2010; 21(3):211-20. PubMed ID: 20158382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels.
    Leonhardt F; Zirlik K; Buchner M; Prinz G; Hechinger AK; Gerlach UV; Fisch P; Schmitt-Gräff A; Reichardt W; Zeiser R
    Leukemia; 2012 Jul; 26(7):1617-29. PubMed ID: 22301676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.